Geneesmiddelenbeleid

This motion concerns the national pharmaceutical policy of the Netherlands. It likely addresses the regulation, accessibility, and pricing of medicines to ensure a sustainable healthcare system and patient safety. This procedure primarily affects healthcare providers, pharmaceutical companies, and patients within the Dutch healthcare system.